Detalhe da pesquisa
1.
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study.
Ann Oncol
; 35(2): 190-199, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37872020
2.
Induction of cell cycle arrest and apoptosis by grape seed procyanidin extract in human bladder cancer BIU87 cells.
Eur Rev Med Pharmacol Sci
; 20(15): 3282-91, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27467005